Testing effectiveness (Phase 2)Study completedNCT02331680
What this trial is testing
A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
Who this might be right for
Chronic Renal Failure
Otsuka Pharmaceutical Co., Ltd. 124